🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Prospective, Multicenter Registry to Observe the Treatment Patterns, Clinical Outcomes, and Decision-Making in Patients With Early Breast Cancer Eligible for EndoPredict® Testing

Recruitingn/aAges 18 Years - anyAllNational and Kapodistrian University of Athens
NCT07389408 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study is planned to observe and document the therapeutic decision-making process, treatment protocols, and clinical outcomes in patients with luminal breast cancer, whether they have undergone EndoPredict® testing or not

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 18 years old. * Histological diagnosis of invasive breast cancer. * T1-T3 tumor size. * 0-3 positive axillary lymph nodes. * Documented ER-positive tumor by immunohistochemistry (≥1% or Allred Score: ≥3/8 or H-score: ≥50/ 300) * Documented HER2-negative tumor by immunohistochemistry and/or in situ hybridization * Subject with signed and dated informed consent form. Exclusion Criteria: * History of another primary malignancy within the last 5 years, except for resected non-melanoma skin cancer. * Pre-operative chemotherapy administered. * Subject without signed and dated informed consent form.
💊

What it tests

  • Not listed
📍

Where

13 sites
"Elena Venizelou" General Hospital, Department of Surgery
Athens, Greece
"Prolipsis" Center, Breast Unit
Athens, Greece
Henry Dunant Hospital Center, 3rd Breast Surgical Department
Athens, Greece
Laiko Hospital, National and Kapodistrian University of Athens, Medical School
Athens, Greece
Mediterraneo Hospital, Breast Clinic
Athens, Greece
Metropolitan General Hospital, 3rd Breast Clinic
Cholargós, Greece
Metropolitan General Hospital, 4th Breast Clinic
Cholargós, Greece
"Apollonio-Theotokos" General Clinic, Department of Surgery
Larissa, Greece

…and 5 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy